Discover how artificial intelligence is transforming drug discovery in this compelling KSNV interview with Phil Mounteney, VP of Science and Technology at Dotmatics.
Learn how AI is helping scientists uncover life-saving medicines faster and more cost-effectively, potentially cutting drug development timelines from ten years to just a few. Phil shares fascinating insights into Dotmatics' innovative AI-ready platform and the future of personalized medicine.
Learn More About Dotmatics
Schedule a meeting with our product experts today for a personalized demo of Luma's AI capabilities.